Author: "Taieb, D." - OpacWWW

Go to position: 1.

Title:: Good clinical practice recommendations for the use of PET/CT in oncology.
Authors:: Salaün PY; Department of Nuclear Medicine, University Hospital of Brest, 5 Avenue Foch, 29609, Brest, France. .
Abgral R; Department of Nuclear Medicine, University Hospital of Brest, 5 Avenue Foch, 29609, Brest, France.
Malard O; Head and Neck, University Hospital of Nantes, Nantes, France.
Querellou-Lefranc S; Department of Nuclear Medicine, University Hospital of Brest, 5 Avenue Foch, 29609, Brest, France.
Quere G; Thoracic Oncology, University Hospital of Brest, Brest, France.
Wartski M; Nuclear Medicine, Cochin Hospital AP-HP, Paris, France.
Coriat R; Gastroenterology, Cochin Hospital AP-HP, Paris, France.
Hindie E; Nuclear Medicine, University Hospital of Bordeaux, Bordeaux, France.
Taieb D; Nuclear Medicine, AP-HM, Marseille, France.
Tabarin A; Endocrinology, University Hospital of Bordeaux, Bordeaux, France.
Girard A; Nuclear Medicine, Eugène Marquis Center, Rennes, France.
Grellier JF; Nuclear Medicine, Foch Hospital, Paris, France.
Brenot-Rossi I; Nuclear Medicine, Paoli-Calmettes Institute, Marseille, France.
Groheux D; Nuclear Medicine, Hopital Saint Louis AP-HP, Paris, France.
Rousseau C; Nuclear Medicine, Ouest Cancer Institute, Nantes, France.
Deandreis D; Nuclear Medicine, Department of Medical Sciences, Citta della Salute e della Scienza, Turin, Italy.
Alberini JL; Nuclear Medicine, Georges-François Leclerc center - François Mitterrand University Hospital, Dijon, France.
Bodet-Milin C; Nuclear Medicine, University Hospital of Nantes, Nantes, France.
Itti E; Nuclear Medicine, Henri Mondor Hospital AP-HP, Paris, France.
Casasnovas O; Hematology, University Hospital Le Bocage, Dijon, France.
Kraeber-Bodere F; Nuclear Medicine, Ouest Cancer Institute, Nantes, France.; Nuclear Medicine, University Hospital of Nantes, Nantes, France.
Moreau P; Hematology, University Hospital of Nantes, Nantes, France.
Philip A; Centre du traitement de la douleur, CHRU de Brest, Brest, France.
Balleyguier C; Radiology, Gustave Roussy Institute, Villejuif, France.
Luciani A; Radiology, Henri Mondor Hospital AP-HP, Paris, France.
Cachin F; Nuclear Medicine, Jean Perrin Cancer Institute, Clermont-Ferrand, France.; Show more
Source:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2020 Jan; Vol. 47 (1), pp. 28-50. Date of Electronic Publication: 2019 Oct 21.
Publication Type:: Journal Article
MeSH Terms:: Neoplasms*/diagnostic imaging
Nuclear Medicine*
Humans ; Medical Oncology ; Positron Emission Tomography Computed Tomography

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 2.

Title:: Early F-FDOPA PET/CT imaging after carbidopa premedication as a valuable diagnostic option in patients with insulinoma.
Authors:: Leroy-Freschini B; Biophysics and Nuclear Medicine, University Hospitals of Strasbourg, Strasbourg, France.
Amodru V; Endocrinology, Diabetes and Metabolic Disorders, La Timone University Hospital, Aix-Marseille University, Marseille, France.
Addeo P; Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France.
Sebag F; Endocrine Surgery, La Timone University Hospital, Aix-Marseille University, Marseille, France.
Vix M; General, Digestive, and Endocrine Surgery, IRCAD-IHU, University of Strasbourg, Strasbourg, France.
Brunaud L; Endocrine and General Surgery, University Hospital of Nancy, Nancy, France.
Klein M; Endocrinology, University Hospital of Nancy, Nancy, France.
Bahougne T; Diabetology, University Hospital of Strasbourg, University of Strasbourg, Strasbourg, France.
Bachellier P; Hepato-Pancreato-Biliary Surgery and Liver Transplantation, University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France.
Castinetti F; Endocrinology, Diabetes and Metabolic Disorders, La Timone University Hospital, Aix-Marseille University, Marseille, France.
Goichot B; Internal Medicine, Diabetes and Metabolic Disorders, University Hospitals of Strasbourg, Strasbourg University, Strasbourg, France.
Chevalier E; Nuclear Medicine, University Hospital of Nancy, Nancy, France.
Taieb D; Nuclear Medicine, La Timone University Hospital, Aix-Marseille University, Marseille, France.; European Center for Research in Medical Imaging, Aix-Marseille University, Marseille, France.
Imperiale A; Biophysics and Nuclear Medicine, University Hospitals of Strasbourg, Strasbourg, France. .; ICube, UMR 7357 Strasbourg University / CNRS & FMTS, Faculty of Medicine of Strasbourg, Strasbourg, France. .; Department of Nuclear Medicine, Hautepierre University Hospital, 1, Avenue Molière, 67098, Strasbourg Cedex, France. .; Show more
Source:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2019 Mar; Vol. 46 (3), pp. 686-695. Date of Electronic Publication: 2019 Jan 07.
Publication Type:: Journal Article
MeSH Terms:: Positron Emission Tomography Computed Tomography*
Carbidopa/*pharmacology
Dihydroxyphenylalanine/*analogs & derivatives
Insulinoma/*diagnostic imaging
Pancreatic Neoplasms/*diagnostic imaging
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Insulin/metabolism ; Insulinoma/metabolism ; Male ; Middle Aged ; Pancreatic Neoplasms/metabolism ; Retrospective Studies ; Time Factors ; Young Adult

Academic Journal

in the bookshelf

Full Text Full Text Details

Go to position: 3.

Title:: Is the information provided by amino acid PET radiopharmaceuticals clinically equivalent in gliomas?
Authors:: Verger A; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille Université, Timone University Hospital, Marseille, France. .; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU Nancy, Lorraine University, Nancy, France. .; IADI, INSERM, UMR 947, Lorraine University, Service de Médecine Nucléaire, rue du Morvan, 54500, Vandoeuvre-les, Nancy, France. .
Taieb D; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille Université, Timone University Hospital, Marseille, France.; CERIMED, Aix-Marseille Université, Marseille, France.
Guedj E; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille Université, Timone University Hospital, Marseille, France.; CERIMED, Aix-Marseille Université, Marseille, France.; Institut de Neurosciences de la Timone, UMR 7289, CNRS Aix-Marseille Université, Marseille, France.; Show more
Source:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2017 Aug; Vol. 44 (8), pp. 1408-1410. Date of Electronic Publication: 2017 Apr 27.
Publication Type:: Letter; Comment
MeSH Terms:: Glioma*
Radiopharmaceuticals*
Amino Acids ; Brain Neoplasms ; Positron-Emission Tomography

Editorial & Opinion

in the bookshelf

Full Text Details

Go to position: 4.

Title:: IDH mutation is paradoxically associated with higher F-FDOPA PET uptake in diffuse grade II and grade III gliomas.
Authors:: Verger A; Department of Nuclear Medicine, APHM, La Timone Hospital, Marseille, France.; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU Nancy, Lorraine University, Nancy, France.; IADI, INSERM, UMR 947, Lorraine University, Nancy, France.
Metellus P; Department of Neurosurgery, Centre Hospitalier Privé Clairval, Marseille, France.; INSERM, UMR 911, Aix-Marseille University, Marseille, France.
Sala Q; Department of Nuclear Medicine, APHM, La Timone Hospital, Marseille, France.
Colin C; INSERM, UMR 911, Aix-Marseille University, Marseille, France.
Bialecki E; Department of Neurosurgery, Centre Hospitalier Privé Clairval, Marseille, France.
Taieb D; Department of Nuclear Medicine, APHM, La Timone Hospital, Marseille, France.; CERIMED, Aix-Marseille University , Marseille, France.
Chinot O; INSERM, UMR 911, Aix-Marseille University, Marseille, France.; Department of Neuro-Oncology, APHM, La Timone Hospital, Marseille, France.
Figarella-Branger D; INSERM, UMR 911, Aix-Marseille University, Marseille, France.; Department of Anatomopathology, APHM, La Timone Hospital, Marseille, France.
Guedj E; Department of Nuclear Medicine, APHM, La Timone Hospital, Marseille, France. .; CERIMED, Aix-Marseille University , Marseille, France. .; Institut de Neurosciences de la Timone, CNRS, UMR 7289, Aix-Marseille University, Marseille, France. .; Service Central de Biophysique et Médecine Nucléaire, Hôpital de la Timone, 264 rue Saint Pierre, 13005, Marseille, France. .; Show more
Source:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2017 Aug; Vol. 44 (8), pp. 1306-1311. Date of Electronic Publication: 2017 Mar 14.
Publication Type:: Journal Article
MeSH Terms:: Mutation*
Positron-Emission Tomography*
Dihydroxyphenylalanine/*analogs & derivatives
Glioma/*metabolism
Glioma/*pathology
Isocitrate Dehydrogenase/*genetics
Adult ; Biological Transport ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/genetics ; Brain Neoplasms/metabolism ; Brain Neoplasms/pathology ; Dihydroxyphenylalanine/metabolism ; Female ; Glioma/diagnostic imaging ; Glioma/genetics ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Retrospective Studies

Academic Journal

in the bookshelf

Full Text Details

Go to position: 5.

Title:: PET/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma.
Authors:: Janssen I; Program in Adult and Reproductive Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Building 10, CRC, Room 1E-3140, 10 Center Drive MSC-1109, Bethesda, MD, 20892, USA.; Department of Radiology and Nuclear Medicine, Section of Nuclear Medicine, University Hospital Schleswig Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Chen CC; Nuclear Medicine Division, Radiology & Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD, 20892, USA.
Millo CM; Positron Emission Tomography Department, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD, 20892, USA.
Ling A; Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, MD, 20892, USA.
Taieb D; Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, Marseille, France.
Lin FI; Cancer Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Adams KT; Program in Adult and Reproductive Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Building 10, CRC, Room 1E-3140, 10 Center Drive MSC-1109, Bethesda, MD, 20892, USA.
Wolf KI; Program in Adult and Reproductive Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Building 10, CRC, Room 1E-3140, 10 Center Drive MSC-1109, Bethesda, MD, 20892, USA.
Herscovitch P; Positron Emission Tomography Department, National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD, 20892, USA.
Fojo AT; Endocrine Oncology Branch, National Cancer Institute, Bethesda, MD, 20892, USA.
Buchmann I; Department of Radiology and Nuclear Medicine, Section of Nuclear Medicine, University Hospital Schleswig Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany.
Kebebew E; Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA.
Pacak K; Program in Adult and Reproductive Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Building 10, CRC, Room 1E-3140, 10 Center Drive MSC-1109, Bethesda, MD, 20892, USA. .; Show more
Source:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2016 Sep; Vol. 43 (10), pp. 1784-91. Date of Electronic Publication: 2016 Mar 21.
Publication Type:: Journal Article
MeSH Terms:: Organometallic Compounds*
Magnetic Resonance Imaging/*methods
Paraganglioma/*diagnostic imaging
Paraganglioma/*secondary
Positron Emission Tomography Computed Tomography/*methods
Tomography, X-Ray Computed/*methods
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Radiopharmaceuticals ; Reproducibility of Results ; Sensitivity and Specificity ; Young Adult